Perrigo (PRGO)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Company Description
Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed.
The company operates through two segments, Consumer Self-Care Americas and Consumer Self-Care International.
The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America.
The segment offers its products under the Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees brand names.
The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 23 countries, primarily in Europe.
The company also offers contract manufacturing services.
Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
Country | IE |
IPO Date | Dec 17, 1991 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 9,140 |
CEO | Patrick Lockwood-Taylor |
Contact Details
Address: The Sharp Building Dublin, IE | |
Website | https://www.perrigo.com |
Stock Details
Ticker Symbol | PRGO |
Exchange | NYSE |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001585364 |
CUSIP Number | G97822103 |
ISIN Number | IE00BGH1M568 |
Employer ID | 00-0000000 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Patrick Lockwood-Taylor | President, Chief Executive Officer & Director |
Eduardo Guarita Bezerra | Executive Vice President & Chief Financial Officer |
Abbie Lennox | EVice President & Chief Scientific Officer |
Bradley Joseph | Vice President of Global Investor Relations & Corporate Communications |
Catherine C. B. Schmelter | Executive Vice President and President of Consumer Self-Care Americas & Global Portfolio Optimization |
Charles Atkinson | Executive Vice President, General Counsel & Secretary |
Mary Reilly-Brest | Director of Global Organizational and Human Resource Development |
Robert Willis | Chief Human Resources Officer & Executive Vice President |
Ronald C. Janish | Chief Transformation Officer and Executive Vice President of Global Operations & Supply Chain |
Shannon Hukill | Senior Director of Technical Operations |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Jan 16, 2025 | 8-K | Current Report |
Dec 20, 2024 | 8-K | Current Report |
Dec 16, 2024 | 25-NSE | Filing |
Dec 10, 2024 | 4 | Filing |
Nov 06, 2024 | 10-Q | Quarterly Report |
Nov 06, 2024 | 8-K/A | [Amend] Current Report |
Nov 06, 2024 | 8-K | Current Report |
Oct 31, 2024 | SC 13G | Statement of acquisition of beneficial ownership b... |
Oct 17, 2024 | 4 | Filing |
Oct 10, 2024 | CERT | Filing |